866-997-4948(US-Canada Toll Free)

United States Anti-Infective Vaccines Market Report 2017

Published By :

QYResearch

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 98 Pages

In this report, the United States Anti-Infective Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anti-Infective Vaccines in these regions, from 2012 to 2022 (forecast).

United States Anti-Infective Vaccines market competition by top manufacturers/players, with Anti-Infective Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva Pharmaceutical Industries
Emergent Biosolutions
Sanofi Pasteur
GlaxoSmithKline
Merck
CSL Limited
Astrazeneca
Pfizer
Serum Institute Of India
Protein Sciences Corporation

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Anti-Bacterial Vaccines
Anti-Viral Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-Infective Vaccines for each application, including
TB
Typhoid
Influenza
Other

Table of Contents

United States Anti-Infective Vaccines Market Report 2017
1 Anti-Infective Vaccines Overview
1.1 Product Overview and Scope of Anti-Infective Vaccines
1.2 Classification of Anti-Infective Vaccines by Product Category
1.2.1 United States Anti-Infective Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Anti-Infective Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Anti-Bacterial Vaccines
1.2.4 Anti-Viral Vaccines
1.3 United States Anti-Infective Vaccines Market by Application/End Users
1.3.1 United States Anti-Infective Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 TB
1.3.3 Typhoid
1.3.4 Influenza
1.3.5 Other
1.4 United States Anti-Infective Vaccines Market by Region
1.4.1 United States Anti-Infective Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Anti-Infective Vaccines Status and Prospect (2012-2022)
1.4.3 Southwest Anti-Infective Vaccines Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Anti-Infective Vaccines Status and Prospect (2012-2022)
1.4.5 New England Anti-Infective Vaccines Status and Prospect (2012-2022)
1.4.6 The South Anti-Infective Vaccines Status and Prospect (2012-2022)
1.4.7 The Midwest Anti-Infective Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anti-Infective Vaccines (2012-2022)
1.5.1 United States Anti-Infective Vaccines Sales and Growth Rate (2012-2022)
1.5.2 United States Anti-Infective Vaccines Revenue and Growth Rate (2012-2022)

2 United States Anti-Infective Vaccines Market Competition by Players/Suppliers
2.1 United States Anti-Infective Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anti-Infective Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anti-Infective Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Anti-Infective Vaccines Market Competitive Situation and Trends
2.4.1 United States Anti-Infective Vaccines Market Concentration Rate
2.4.2 United States Anti-Infective Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anti-Infective Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anti-Infective Vaccines Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Anti-Infective Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Anti-Infective Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Anti-Infective Vaccines Price by Region (2012-2017)

4 United States Anti-Infective Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Anti-Infective Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anti-Infective Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Infective Vaccines Price by Type (2012-2017)
4.4 United States Anti-Infective Vaccines Sales Growth Rate by Type (2012-2017)

5 United States Anti-Infective Vaccines Sales (Volume) by Application (2012-2017)
5.1 United States Anti-Infective Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Infective Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Anti-Infective Vaccines Players/Suppliers Profiles and Sales Data
6.1 Teva Pharmaceutical Industries
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Infective Vaccines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Teva Pharmaceutical Industries Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Emergent Biosolutions
6.2.2 Anti-Infective Vaccines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Emergent Biosolutions Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi Pasteur
6.3.2 Anti-Infective Vaccines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Anti-Infective Vaccines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck
6.5.2 Anti-Infective Vaccines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 CSL Limited
6.6.2 Anti-Infective Vaccines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 CSL Limited Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Astrazeneca
6.7.2 Anti-Infective Vaccines Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Astrazeneca Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.2 Anti-Infective Vaccines Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pfizer Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Serum Institute Of India
6.9.2 Anti-Infective Vaccines Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Serum Institute Of India Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Protein Sciences Corporation
6.10.2 Anti-Infective Vaccines Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Protein Sciences Corporation Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Anti-Infective Vaccines Manufacturing Cost Analysis
7.1 Anti-Infective Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Infective Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Infective Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Infective Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Anti-Infective Vaccines Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Anti-Infective Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anti-Infective Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Anti-Infective Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Anti-Infective Vaccines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Anti-Infective Vaccines
Figure United States Anti-Infective Vaccines Market Size (M ML) by Type (2012-2022)
Figure United States Anti-Infective Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-Bacterial Vaccines Product Picture
Figure Anti-Viral Vaccines Product Picture
Figure United States Anti-Infective Vaccines Market Size (M ML) by Application (2012-2022)
Figure United States Sales Market Share of Anti-Infective Vaccines by Application in 2016
Figure TB Examples
Figure Typhoid Examples
Figure Influenza Examples
Figure Other Examples
Figure United States Anti-Infective Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Infective Vaccines Sales (M ML) and Growth Rate (2012-2022)
Figure United States Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Infective Vaccines Market Major Players Product Sales Volume (M ML) (2012-2017)
Table United States Anti-Infective Vaccines Sales (M ML) of Key Players/Suppliers (2012-2017)
Table United States Anti-Infective Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Infective Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Anti-Infective Vaccines Sales Share by Players/Suppliers
Figure United States Anti-Infective Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anti-Infective Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anti-Infective Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Infective Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Anti-Infective Vaccines Revenue Share by Players/Suppliers
Table United States Market Anti-Infective Vaccines Average Price (USD/ML) of Key Players/Suppliers (2012-2017)
Figure United States Market Anti-Infective Vaccines Average Price (USD/ML) of Key Players/Suppliers in 2016
Figure United States Anti-Infective Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Anti-Infective Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anti-Infective Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anti-Infective Vaccines Product Category
Table United States Anti-Infective Vaccines Sales (M ML) by Region (2012-2017)
Table United States Anti-Infective Vaccines Sales Share by Region (2012-2017)
Figure United States Anti-Infective Vaccines Sales Share by Region (2012-2017)
Figure United States Anti-Infective Vaccines Sales Market Share by Region in 2016
Table United States Anti-Infective Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anti-Infective Vaccines Revenue Share by Region (2012-2017)
Figure United States Anti-Infective Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Anti-Infective Vaccines Revenue Market Share by Region in 2016
Table United States Anti-Infective Vaccines Price (USD/ML) by Region (2012-2017)
Table United States Anti-Infective Vaccines Sales (M ML) by Type (2012-2017)
Table United States Anti-Infective Vaccines Sales Share by Type (2012-2017)
Figure United States Anti-Infective Vaccines Sales Share by Type (2012-2017)
Figure United States Anti-Infective Vaccines Sales Market Share by Type in 2016
Table United States Anti-Infective Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anti-Infective Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Infective Vaccines by Type (2012-2017)
Figure Revenue Market Share of Anti-Infective Vaccines by Type in 2016
Table United States Anti-Infective Vaccines Price (USD/ML) by Types (2012-2017)
Figure United States Anti-Infective Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Anti-Infective Vaccines Sales (M ML) by Application (2012-2017)
Table United States Anti-Infective Vaccines Sales Market Share by Application (2012-2017)
Figure United States Anti-Infective Vaccines Sales Market Share by Application (2012-2017)
Figure United States Anti-Infective Vaccines Sales Market Share by Application in 2016
Table United States Anti-Infective Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Infective Vaccines Sales Growth Rate by Application (2012-2017)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Emergent Biosolutions Basic Information List
Table Emergent Biosolutions Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Emergent Biosolutions Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Emergent Biosolutions Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Emergent Biosolutions Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Merck Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Merck Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure CSL Limited Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure CSL Limited Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure CSL Limited Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Astrazeneca Basic Information List
Table Astrazeneca Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Astrazeneca Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Astrazeneca Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Astrazeneca Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Pfizer Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Pfizer Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Pfizer Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Serum Institute Of India Basic Information List
Table Serum Institute Of India Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Serum Institute Of India Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Serum Institute Of India Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Serum Institute Of India Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Protein Sciences Corporation Basic Information List
Table Protein Sciences Corporation Anti-Infective Vaccines Sales (M ML), Revenue (Million USD), Price (USD/ML) and Gross Margin (2012-2017)
Figure Protein Sciences Corporation Anti-Infective Vaccines Sales Growth Rate (2012-2017)
Figure Protein Sciences Corporation Anti-Infective Vaccines Sales Market Share in United States (2012-2017)
Figure Protein Sciences Corporation Anti-Infective Vaccines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Infective Vaccines
Figure Manufacturing Process Analysis of Anti-Infective Vaccines
Figure Anti-Infective Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Anti-Infective Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Anti-Infective Vaccines
Table Distributors/Traders List
Figure United States Anti-Infective Vaccines Sales Volume (M ML) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Infective Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Infective Vaccines Price (USD/ML) Trend Forecast (2017-2022)
Table United States Anti-Infective Vaccines Sales Volume (M ML) Forecast by Type (2017-2022)
Figure United States Anti-Infective Vaccines Sales Volume (M ML) Forecast by Type (2017-2022)
Figure United States Anti-Infective Vaccines Sales Volume (M ML) Forecast by Type in 2022
Table United States Anti-Infective Vaccines Sales Volume (M ML) Forecast by Application (2017-2022)
Figure United States Anti-Infective Vaccines Sales Volume (M ML) Forecast by Application (2017-2022)
Figure United States Anti-Infective Vaccines Sales Volume (M ML) Forecast by Application in 2022
Table United States Anti-Infective Vaccines Sales Volume (M ML) Forecast by Region (2017-2022)
Table United States Anti-Infective Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Infective Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Infective Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *